Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX)

Price 54.00p on 22-10-2024 at 16:30:01
Change 0.00p 0%
Buy 55.00p
Sell 53.00p
Buy / Sell TRX Shares
Last Trade: Sell 1,514.00 at 53.625p
Day's Volume: 37,201
Last Close: 54.00p
Open: 54.00p
ISIN: GB00BNTXR104
Day's Range 54.00p - 54.00p
52wk Range: 50.00p - 74.00p
Market Capitalisation: £38m
VWAP: 53.24557p
Shares in Issue: 71m

Recent Trades History Tissue Regenix Group (TRX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,514 53.625p Ordinary
14:29:19 - 22-Oct-24
Sell* 400 53.84p Ordinary
13:30:52 - 22-Oct-24
Unknown* 22,500 53.00p Ordinary
10:59:45 - 22-Oct-24
Sell* 5 53.60p Ordinary
11:51:48 - 22-Oct-24
Sell* 1,696 53.90p Ordinary
11:30:25 - 22-Oct-24
Sell* 85 53.60p Ordinary
11:04:23 - 22-Oct-24
Sell* 4,839 53.50p Ordinary
11:01:40 - 22-Oct-24
Sell* 6,000 53.625p Ordinary
10:59:59 - 22-Oct-24
Buy* 9 54.90p Ordinary
10:03:09 - 22-Oct-24
Sell* 126 53.625p Ordinary
09:59:15 - 22-Oct-24

Share Price History for Tissue Regenix Group

Time period:
to
Date Open High Low Close Volume

Share News for Tissue Regenix Group

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2024 11:31

Read More

IN BRIEF: Tissue Regenix eyes revenue and adjusted profit growth

16th Jul 2024 11:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says trading in the first half of 2024 was strong, as it expects revenue to have climbed 16% to USD16.4 million from USD14.1 million a year prior. "The BioRinse segment continued to deliver solid growth driven by increased efficiencies, while the commercial reorganisation of the dCELL segment continued to show benefits, demonstrating robust growth within the period," Tissue Regenix says. It will report its full half-year results on September 10. Read More

Tissue Regenix purchases Texas facility to generate cost savings

14th Jun 2024 14:36

(Alliance News) - Tissue Regenix Group PLC on Friday said it purchased an existing facility as part of phase 1 and 2 expansion plans. Read More

UK shareholder meetings calendar - next 7 days

18th Apr 2024 14:12

Read More

FTSE 100 Latest
Value8,306.54
Change-11.70

Login to your account

Forgot Password?

Not Registered